Toxoplasmosis is considered to be the third leading cause of death attributed to foodborne illness in the United States. More than 60 million men, women, and children in the U.S. carry the Toxoplasma parasite, but very few have symptoms because the immune system usually keeps the parasite from causing illness. However, women newly infected with Toxoplasma during pregnancy and anyone with a compromised immune system should be aware that toxoplasmosis can have severe consequences for them.
A team of researchers has found that a dangerous type of parasite that affects the brain, maintains a stable supply of essential nutrients as it replicates in the host cell. In an unexpected turn of events, the body itself delivers food to the harmful predator.
A shocking new report from a nonprofit organization called The White Coat Waste Project published this week found that the U.S. Department of Agriculture (USDA) has been conducting some abhorrent and bizarre experiments with cats and dogs.
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy -; and many other potential applications -; is 100 percent sensitive and 100 percent specific for detecting the presence of this life-damaging microorganism.
Good news for cat lovers! A latest study has found that a parasite infestation found in cat feces could make a person an entrepreneur. Cat feces commonly contain parasite Toxoplasma gondii and its infection can often go unnoticed in most individuals. A new study has found that people who have had T. gondii infection are around 1.4 times more likely to major in business studies compared to those who were not infected.
It was 2015 when Martin Shkreli, then CEO of Turing Pharmaceuticals and the notorious "pharma bro," jacked up the cost of the lifesaving drug Daraprim by 5,000 percent. Overnight, its price tag skyrocketed from $13.50 a pill to $750.
A Singapore-India collaborative research project between the Singapore University of Technology & Design and CSIR-National Chemical Laboratories completed phenotypic screening of a large collection of potent chemical inhibitors (known as MMV Malaria Box), against pathogenic parasites Toxoplasma gondii and Plasmodium falciparum, causative agents of human toxoplasmosis and malaria.
Sleeping sickness could use a more encompassing moniker. An international study from the O'Donnell Brain Institute shows one of Africa's most lethal diseases is actually a circadian rhythm disorder caused by the acceleration of biological clocks controlling a range of vital functions besides sleep.
A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.
More than 2 billion people – nearly one out of every three humans on earth, including about 60 million people in the United States – have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.
The Immunologicals Group of The Binding Site is pleased to announce the launch of a number of new monoclonal antibodies and recombinant antigens focused on a variety of infectious/contagious disease states – including Cytomegalovirus (CMV), Hepatitis, HIV, Rubella, Syphilis, and Toxoplasmosis.
Congenital toxoplasmosis - an infection passed on from mother to fetus - has a high disease burden per case. However, only a relatively small number of cases occur each year in Denmark.
An international study led by researchers at Monash University' Biomedicine Discovery Institute (BDI) has shone light on the way the Hepatitis C Virus (HCV) hijacks the communication systems in the host cells it infects, uncovering potential new therapeutic targets for the disease.
The parasite that causes deadly sleeping sickness has its own biological clock that makes it more vulnerable to medications during the afternoon, according to international research that may help improve treatments for one of Africa's most lethal diseases.
Scientists from the universities of Granada and Valencia have developed a new molecular method for determining the presence of the parasite Toxoplasma gondii, which causes toxoplasmosis, in samples of ham.
An estimated 1.2 million people live with HIV in the United States, with nearly 13 percent being unaware of their infection.
The relation between Zika virus and microcephaly is widely assumed to be causal because of strong evidence of an association. However, evidence so far comes from case reports, case series, modelling studies, and preliminary reports from cohort studies – none of which have included appropriate control groups.
A recent study published by Brazilian researchers from the D'Or Institute for Research and Education, Federal University of Rio de Janeiro, Institute for Research Professor Amorim Neto, alongside Tel Aviv University and the Boston Children's Hospital in the US, indicates that microcephaly, a very usual feature in cases of Zika virus gestational infection, is just one of several observed brain changes.
New research critical to treatment for chronic toxoplasmosis, one of the most common parasitic diseases worldwide, was published in the Journal of Experimental Medicine.
Griffith University tropical disease researchers have joined together with a host of international laboratories to advance drug discovery for major topical diseases through the creation and testing of the Malaria Box.
In the July 14 edition of Scientific Reports (Nature), 39 researchers from 14 leading institutions in the United States, United Kingdom and France suggest novel approaches that could hasten the development of better medications for people suffering from toxoplasmosis.